APN News & Media Limited

APN Details
· Offloading Australian Regional Media business: APN News & Media Limited (ASX: APN) stock lost over 4.1% on January 18, 2017. The group is selling their Australian Regional Media (ARM) to a subsidiary of News Corp and got the ACCC approval for this. With the sale, the group intends to further focus on their media sectors of radio and outdoor. Accordingly, APN acquired the rest of the (50%) of Adshel stake to speed-up their digital investment program, while enhancing their integrated marketing campaigns.

· Recommendation: APN stock lost over 25.5% in the last six months (as on January 17, 2017) and we believe this negative momentum in the stock would continue. We maintain our “Expensive” recommendation at the current price of – $ 2.60

ImpediMed Limited

IPD Details
· Board changes: ImpediMed Limited (ASX: IPD) stock lost over 7.3% on January 18, 2017. Ms Elizabeth Gaines is set to retire from the group’s Board on February 03, 2017 and is getting appointed as the Chief Financial Officer at Fortescue Metals Group Limited from next month. On the other side, the group’s revenues from oncology rose 60% in FY16 against the prior year. The group is positioning itself to address the market opportunity from lymphedema while establishing BIS technology as the gold standard for measuring fluid balance, body composition and hydration. IPD’s core products, SOZO device scans and L-Dex lymphedema detection product promises solid potential on a long-term basis

· Recommendation: IPD stock lost over 42.4% in the last three months (as of January 17, 2017) and the pressure is expected to continue. We give an “Expensive” recommendation on the stock at the current price of - $ 0.82, and would review the stock at later date. 

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.